Pharmaceutical company Collegium Pharmaceutical (NASDAQ:COLL) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 12.9% year on year to $205.4 million. The company’s full-year revenue guidance of $815 million at the midpoint came in 1% abov

Despite underperforming the Dow Jones Industrial Average over the past year, Vertex continues to earn moderate bullish support from analysts.

Egg and butter company Vital Farms (NASDAQ:VITL) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 28.7% year on year to $213.6 million. On the other hand, the company’s full-year revenue guidance of $910 million at the midpoint came in 3

Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from scaled industry giants and can be disrupted by new innovat

Infrastructure engineering software company Bentley Systems (NASDAQ:BSY) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 11.9% year on year to $391.6 million. The company’s full-year revenue guidance of $1.7 billion a

Casino, sports betting and entertainment operator PENN Entertainment (NASDAQ:PENN) announced better-than-expected revenue in Q4 CY2025, with sales up 8.2% year on year to $1.81 billion. Its non-GAAP profit of $0.07 per share was significantly above analys

As enriched uranium grows scarce and prices surge, this stock could fit well into a diversified energy portfolio.

Banks play a critical role in the financial system, providing everything from commercial loans to wealth management and payment processing services. But worries about an economic slowdown and potential credit deterioration have kept sentiment in check, an

Micron Technology has outperformed other semiconductor stocks over the past year, and analysts remain highly optimistic about the stock’s growth potential.

Medication company Viatris (NASDAQ:VTRS) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 5% year on year to $3.7 billion. The company’s full-year revenue guidance of $14.7 billion at the midpoint came in 2.3% above analyst

Home warranty company Frontdoor (NASDAQ:FTDR) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 13.1% year on year to $433 million. On the other hand, next quarter’s revenue guidance of $442.5 million was less impressive,

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their

Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 4% year on year to $406.8 million. On the other hand, the company’s full-year revenue guidance of $1.43 billion at the midpoint

Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with competition, ranging from giants with vast resources

Citigroup Inc., which reviewed the published outlooks of some of the world’s biggest asset managers, found that funds had added to long positions in markets across Asia, Latin America, as well as Europe, the Middle East and Africa. Emerging debt carries